Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its first quarter of fiscal year 2014 ended November 30, 2013 (1QFY14).
1QFY14 highlights compared with 1QFY13:
•Net sales increased 15.3% to first-quarter record $2.641 million from $2.291 million
Help employers find you! Check out all the jobs and post your resume.
